Epidemiology, Pathophysiology, and Prognosis of Heart Failure in Older Adults

Heart Failure Clinics

Volumn 13, Issue 3, 2017, Pages 417-426

  Dharmarajan, Kumar ^a   Rich, Michael W ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Epidemiology; Heart failure; Hospitalization; Mortality; Pathophysiology; Prognosis; Rehospitalization

Indexed keywords

CARDIOVASCULAR MORTALITY; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; AGE; AGED; FEMALE; MALE; UNITED STATES; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; MALE; PROGNOSIS; UNITED STATES;

EID: 85020857344     PISSN: 15517136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hfc.2017.02.001     Document Type: Review

References (71)

1. Agency for Healthcare Research and Quality. HCUP Statistical Brief 66: Medicare hospital stays: comparisons between the fee-for-service plan and alternative plans. 2006. Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb66.jsp. Accessed November 26, 2016.
2. Heidenreich, P.A., Albert, N.M., Allen, L.A., et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6:3 (2013), 606–619.
3. Yancy, C.W., Jessup, M., Bozkurt, B., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:16 (2013), e240–e327.
4. Roger, V.L., Epidemiology of heart failure. Circ Res 113:6 (2013), 646–659.
5. Dunlay, S.M., Roger, V.L., Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep 11:4 (2014), 404–415.
6. McKee, P.A., Castelli, W.P., McNamara, P.M., et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 285:26 (1971), 1441–1446.
7. Carlson, K.J., Lee, D.C., Goroll, A.H., et al. An analysis of physicians' reasons for prescribing long-term digitalis therapy in outpatients. J Chronic Dis 38:9 (1985), 733–739.
8. Eriksson, H., Caidahl, K., Larsson, B., et al. Cardiac and pulmonary causes of dyspnoea–validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J 8:9 (1987), 1007–1014.
9. Schellenbaum, G.D., Rea, T.D., Heckbert, S.R., et al. Survival associated with two sets of diagnostic criteria for congestive heart failure. Am J Epidemiol 160:7 (2004), 628–635.
10. Mosterd, A., Deckers, J.W., Hoes, A.W., et al. Classification of heart failure in population based research: an assessment of six heart failure scores. Eur J Epidemiol 13:5 (1997), 491–502.
11. Rosamond, W.D., Chang, P.P., Baggett, C., et al. Classification of heart failure in the atherosclerosis risk in communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail 5:2 (2012), 152–159.
12. Mozaffarian, D., Benjamin, E.J., Go, A.S., et al. Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133:4 (2016), e38–e360.
13. National Institutes of Health, Incidence and prevalence: 2006 chart book on cardiovascular and lung diseases, 2006, National Heart, Lung, and Blood Institute, Bethesda (MD).
14. Barker, W.H., Mullooly, J.P., Getchell, W., Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994. Circulation 113:6 (2006), 799–805.
15. Bahrami, H., Kronmal, R., Bluemke, D.A., et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med 168:19 (2008), 2138–2145.
16. Loehr, L.R., Rosamond, W.D., Chang, P.P., et al. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 101:7 (2008), 1016–1022.
17. Hawkins, N.M., Jhund, P.S., McMurray, J.J., et al. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail 14:2 (2012), 138–146.
18. Lloyd-Jones, D.M., Larson, M.G., Leip, E.P., et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 106:24 (2002), 3068–3072.
19. Huffman, M.D., Berry, J.D., Ning, H., et al. Lifetime risk for heart failure among white and black Americans: cardiovascular lifetime risk pooling project. J Am Coll Cardiol 61:14 (2013), 1510–1517.
20. Bleumink, G.S., Knetsch, A.M., Sturkenboom, M.C., et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 25:18 (2004), 1614–1619.
21. Gerber, Y., Weston, S.A., Redfield, M.M., et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med 175:6 (2015), 996–1004.
22. Curtis, L.H., Whellan, D.J., Hammill, B.G., et al. Incidence and prevalence of heart failure in elderly persons, 1994-2003. Arch Intern Med 168:4 (2008), 418–424.
23. Yeung, D.F., Boom, N.K., Guo, H., et al. Trends in the incidence and outcomes of heart failure in Ontario, Canada: 1997 to 2007. CMAJ 184:14 (2012), E765–E773.
24. Jhund, P.S., Macintyre, K., Simpson, C.R., et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 119:4 (2009), 515–523.
25. Zarrinkoub, R., Wettermark, B., Wandell, P., et al. The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden. Eur J Heart Fail 15:9 (2013), 995–1002.
26. Folsom, A.R., Yamagishi, K., Hozawa, A., et al. Absolute and attributable risks of heart failure incidence in relation to optimal risk factors. Circ Heart Fail 2:1 (2009), 11–17.
27. He, J., Ogden, L.G., Bazzano, L.A., et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161:7 (2001), 996–1002.
28. Roth, G.A., Forouzanfar, M.H., Moran, A.E., et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med 372:14 (2015), 1333–1341.
29. Bursi, F., Weston, S.A., Redfield, M.M., et al. Systolic and diastolic heart failure in the community. JAMA 296:18 (2006), 2209–2216.
30. Fonarow, G.C., Stough, W.G., Abraham, W.T., et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50:8 (2007), 768–777.
31. West, R., Liang, L., Fonarow, G.C., et al. Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE-US registry and ADHERE-International registry. Eur J Heart Fail 13:9 (2011), 945–952.
32. Gottdiener, J.S., Arnold, A.M., Aurigemma, G.P., et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 35:6 (2000), 1628–1637.
33. Avery, C.L., Loehr, L.R., Baggett, C., et al. The population burden of heart failure attributable to modifiable risk factors: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol 60:17 (2012), 1640–1646.
34. Oxenham, H., Sharpe, N., Cardiovascular aging and heart failure. Eur J Heart Fail 5:4 (2003), 427–434.
35. Fleg, J.L., Strait, J., Age-associated changes in cardiovascular structure and function: a fertile milieu for future disease. Heart Fail Rev 17:4–5 (2012), 545–554.
36. Lakatta, E.G., Diminished beta-adrenergic modulation of cardiovascular function in advanced age. Cardiol Clin 4:2 (1986), 185–200.
37. Loffredo, F.S., Nikolova, A.P., Pancoast, J.R., et al. Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium. Circ Res 115:1 (2014), 97–107.
38. Olivetti, G., Melissari, M., Capasso, J.M., et al. Cardiomyopathy of the aging human heart. Myocyte loss and reactive cellular hypertrophy. Circ Res 68:6 (1991), 1560–1568.
39. Burgess, M.L., McCrea, J.C., Hedrick, H.L., Age-associated changes in cardiac matrix and integrins. Mech Ageing Dev 122:15 (2001), 1739–1756.
40. Eghbali, M., Eghbali, M., Robinson, T.F., et al. Collagen accumulation in heart ventricles as a function of growth and aging. Cardiovasc Res 23:8 (1989), 723–729.
41. Lakatta, E.G., Levy, D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease. Circulation 107:1 (2003), 139–146.
42. Semba, R.D., Sun, K., Schwartz, A.V., et al. Serum carboxymethyl-lysine, an advanced glycation end product, is associated with arterial stiffness in older adults. J Hypertens 33:4 (2015), 797–803 [discussion: 803].
43. Cernadas, M.R., Sanchez de Miguel, L., Garcia-Duran, M., et al. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res 83:3 (1998), 279–286.
44. Ronco, C., Haapio, M., House, A.A., et al. Cardiorenal syndrome. J Am Coll Cardiol 52:19 (2008), 1527–1539.
45. Ronco, C., Di Lullo, L., Cardiorenal syndrome. Heart Fail Clin 10:2 (2014), 251–280.
46. Silverberg, D., Wexler, D., Blum, M., et al. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 13:2 (2004), 163–170.
47. Barr, R.G., Bluemke, D.A., Ahmed, F.S., et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 362:3 (2010), 217–227.
48. Grau, M., Barr, R.G., Lima, J.A., et al. Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies. Chest 144:1 (2013), 136–144.
49. Sajkov, D., McEvoy, R.D., Obstructive sleep apnea and pulmonary hypertension. Prog Cardiovasc Dis 51:5 (2009), 363–370.
50. Page, R.L. 2nd, O'Bryant, C.L., Cheng, D., et al. Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association. Circulation 134:6 (2016), e32–e69.
51. Dharmarajan, K., Strait, K.M., Lagu, T., et al. Acute decompensated heart failure is routinely treated as a cardiopulmonary syndrome. PLoS One, 8(10), 2013, e78222.
52. Dharmarajan, K., Dunlay, S.M., Multimorbidity in older adults with heart failure. Clin Geriatr Med 32:2 (2016), 277–289.
53. Mangoni, A.A., Jackson, S.H., Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 57:1 (2004), 6–14.
54. Dharmarajan, K., Strait, K.M., Tinetti, M.E., et al. Treatment for multiple acute cardiopulmonary conditions in older adults hospitalized with pneumonia, chronic obstructive pulmonary disease, or heart failure. J Am Geriatr Soc 64:8 (2016), 1574–1582.
55. Stewart, S., MacIntyre, K., Hole, D.J., et al. More ‘malignant’ than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 3:3 (2001), 315–322.
56. Levy, D., Kenchaiah, S., Larson, M.G., et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med 347:18 (2002), 1397–1402.
57. Roger, V.L., Weston, S.A., Redfield, M.M., et al. Trends in heart failure incidence and survival in a community-based population. JAMA 292:3 (2004), 344–350.
58. Merlo, M., Pivetta, A., Pinamonti, B., et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail 16:3 (2014), 317–324.
59. Bueno, H., Ross, J.S., Wang, Y., et al. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 303:21 (2010), 2141–2147.
60. Chen, J., Normand, S.L., Wang, Y., et al. National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA 306:15 (2011), 1669–1678.
61. Owan, T.E., Hodge, D.O., Herges, R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355:3 (2006), 251–259.
62. Bhatia, R.S., Tu, J.V., Lee, D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355:3 (2006), 260–269.
63. Allen, L.A., Hernandez, A.F., Peterson, E.D., et al. Discharge to a skilled nursing facility and subsequent clinical outcomes among older patients hospitalized for heart failure. Circ Heart Fail 4:3 (2011), 293–300.
64. Dunlay, S.M., Redfield, M.M., Weston, S.A., et al. Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol 54:18 (2009), 1695–1702.
65. Chen, J., Dharmarajan, K., Wang, Y., et al. National trends in heart failure hospital stay rates, 2001 to 2009. J Am Coll Cardiol 61:10 (2013), 1078–1088.
66. Agarwal, S.K., Wruck, L., Quibrera, M., et al. Temporal trends in hospitalization for acute decompensated heart failure in the United States, 1998-2011. Am J Epidemiol 183:5 (2016), 462–470.
67. Dharmarajan, K., Hsieh, A.F., Lin, Z., et al. Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 309:4 (2013), 355–363.
68. Dharmarajan, K., Hsieh, A.F., Kulkarni, V.T., et al. Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia: retrospective cohort study. BMJ, 350, 2015, h411.
69. Dharmarajan, K., Comprehensive strategies to reduce readmissions in older patients with cardiovascular disease. Can J Cardiol 32:11 (2016), 1306–1314.
70. Dharmarajan, K., Hsieh, A., Dreyer, R.P., et al. Relationship between age and trajectories of rehospitalization risk in older adults. J Am Geriatr Soc 65:2 (2016), 421–426.
71. Ranasinghe, I., Wang, Y., Dharmarajan, K., et al. Readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia among young and middle-aged adults: a retrospective observational cohort study. PLoS Med, 11(9), 2014, e1001737.